The upgrade to Overweight suggests that Morgan Stanley sees R1 RCM as a good investment opportunity and expects the stock to outperform. However, the reduction in the price target could slightly temper investor enthusiasm, as it may indicate a more conservative view on the company's valuation or growth prospects. Overall, the upgrade is likely to have a more significant positive impact on the stock price in the short term compared to the minor adjustment in the price target.